US › Healthcare

Brainsway Ltd (BWAY)

US · Healthcare · Medical Devices

$15.80-0.06%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$15.5M
Revenue YoY
+34.6%
Net profit
$2.3M
Profit YoY
+106.9%
EPS
$0.06
EPS estimate
$0.05
Net margin
14.7%

EPS came in at 0.06 against a street estimate of 0.05 — a beat of 20.0%.

Key statistics

Market cap
$611.2M
P/E
69.2
Forward P/E
36.2
P/B
8.06
Book value
$1.99
EPS (TTM)
$0.22
52-week high
$17.35
52-week low
$5.70
50-day MA
$15.04
200-day MA
$12.40
Beta
0.15

Analyst view

Analysts rate Brainsway Ltd a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $17.67.

Shareholding

Insiders
6.02%
Institutions
29.84%

Largest institutional holders

FundStake
Valor Management LLC13.24%
Masters Capital Management LLC4.11%
Acadian Asset Management LLC2.04%
Essex Investment Management Company, LLC1.54%
Renaissance Technologies Corp1.29%
Cresset Asset Management, LLC0.78%
Y.D. More Investments Ltd0.68%
SEI Investments Co0.56%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Brainsway Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.